Comptroller General review of influenza vaccine requirements of Department of Defense

(a) In general The Comptroller General of the United States shall conduct a review of the influenza vaccine requirements of the Department of Defense and the considerations that led to recent policy changes with respect to such requirements as of the date of the enactment of this Act. (b) Elements The review required under subsection (a) shall include the following: (1) A description of previous and current influenza vaccination requirements, as of the date of the enactment of this Act, described in— (A) Department of Defense Instruction 6205.02 relating to the Department of Defense Immunization Program; (B) updated guidance on influenza vaccination issued by the Secretary of Defense in an April 20, 2026, memorandum; and (C) relevant implementing guidance for any such requirements or guidance. (2) An analysis of any risks, benefits, or other matters considered by the Secretary of Defense with respect to the updated guidance specified in paragraph (1)(B). (3) The impact of such updated guidance on the ability of the Department to meet medical readiness goals established in Department of Defense Instruction 6025.19 relating to the Individual Medical Readiness Program. (4) Such other matters as the Comptroller General determines relevant. (c) Briefing Not later than September 30, 2027, the Comptroller General shall provide to the Committees on Armed Services of the Senate and the House of Representatives a briefing on the results of the review conducted under subsection (a), with a report to follow at a mutually agreed upon time and in a mutually agreed upon format.